Zbog toga filgrastim nije indikovan u ovim stanjima. Neophodan je poseban oprez u razlikovanju dijagnoza blastne transformacije hroni?ne mijeloidne leukemije i akutne mijeloidne leukemije (AML).The advised beginning dosage of NIVESTYM is 5 mcg/kg/dayâ???administered as an individual each day injection by subcutaneous injectionâ???by small intrave